Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 65/100

Palatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023

Key Takeaway: Palatin Technologies, Inc. will report its second quarter fiscal year 2023 results on February 15, 2023, prior to the U.S. financial market opening. The announcement will be followed by a live conference call at 11:00 a.m. ET on the same day, which will include discussions on the company's performance and ongoing development programs. All interested parties can access the call via a dedicated phone line or a webcast through Palatin's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palatin is set to release its second quarter fiscal results, indicating operational transparency.
  • The company will provide updates on its development programs during the conference call.
  • Palatin is focusing on first-in-class medicines for significant unmet medical needs.

Full Press Release Details

CRANBURY, N.J., Feb. 10, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2023 operating results on Wednesday, February 15, 2023, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 15, 2023, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q2 Fiscal Year 2023 Results Press Release 02/15/2023 at 7:30 a.m. ET
Q2 Fiscal Year 2023 Conference Call-Live 02/15/2023 at 11:00 a.m. ET
US Toll Free Dial-In Number: 1-888-506-0062
International Dial-In Number: 1-973-528-0011
Participant Access Code: 928705
Q2 Fiscal Year 2023 Conference Call-Replay 02/15/2023-03/01/2023
US Toll Free Dial-In Number: 1-877-481-4010
International Dial-In Number: 1-919-882-2331
Participant Access Code: 47637
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by accessing this link.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Palatin announce its Q2 fiscal year 2023 results?

Palatin will announce its Q2 fiscal year 2023 results on February 15, 2023.

What time is the conference call for Palatin's Q2 results?

The conference call will take place at 11:00 a.m. ET on February 15, 2023.

How can I access Palatin's audio webcast?

The audio webcast can be accessed through Palatin's website under 'Investors-Webcasts.'

What is Palatin Technologies focused on developing?

Palatin develops first-in-class medicines modulating melanocortin receptor systems.

What is Palatin's strategy for product commercial potential?

Palatin aims to develop products and form marketing collaborations with industry leaders.

Last updated: Feb 10, 2023